Dermatologic

RSS

Preparation and use of 5alpha-reductase type 1 inhibitors described by Merck & Co.

June 6, 1997

Penederm receives SBIR grant for research on vitamin D derivative

June 5, 1997

Bristol-Myers Squibb selects diacid for development as antipsoriatic

June 4, 1997

ProCyte launches GraftCyte products

May 28, 1997

Dusa reports progress in phase III trial of Levulan PDT

May 23, 1997

VIMRx acquires worldwide rights to wound-healing agent

May 21, 1997

Ointment formulation of BioCryst's BCX-34 enters phase II for psoriasis

May 20, 1997

Safety, pharmacological, phase I and early phase II results for SM-10902

May 20, 1997

CytoMed initiates phase II trials of CMI-392

May 9, 1997

Dermik introduces combination acne therapy in South Africa

May 9, 1997